14 Sep - 15 Sep '19

1st ECTORS meeting

The content of this meeting is centred around the state of the art of regenerative medicine in organ transplantation and its road to clinical application.

1st ECTORS meeting

Regenerative medicine in organ transplantation

Programme Information:




09:00 – 19:00 first ECTORS meeting

09:00 – 09:30            Welcome and review 2008 - 2018

Marc Dahlke, Regensburg, Germany

Martin Hoogduijn, Rotterdam, The Netherlands

09.30-11.00   Session 1: Stem cells new developments


Marc Dahlke, Regensburg, Germany

Martin Hoogduijn, Rotterdam, The Netherlands

MSC mechanisms of action

Francesco Dazzi, London, United Kingdom

MSC in organ injury

Rafael Kramann, Aachen, Germany

Liver organoids from adult stem cells

Luc van der Laan, Rotterdam, The Netherlands


11.00-11.30 Coffee/tea


11.30-13.00 Session 2: Cell therapy clinical trials

Chairs:                      to be announced


MSC in clinical kidney transplantation

Giuseppe Remuzzi, Bergamo, Italy


From phase 1 to phase 2 clinical trials with MSC in kidney transplantation

Marlies Reinders, Leiden, The Netherlands


Lessons learned from stem cell clinical trials

Jens Kastrup, Copenhagen, Denmark


13.00-14.00 Lunch

14.00-15.30 Session 3: Organ reconditioning

Chairs:                      to be announced

Kidney machine perfusion

Sarah Hosgood, Cambridge, United Kingdom

Liver machine perfusion

Nicholas Gilbo, Leuven, Belgium

Regeneration on the pump

Rutger Ploeg, Oxford, United Kingdom


15.30-16.00 Coffee/tea


16.00-17.30 Session 4: Corporate session

to be announced








9.00-10.00 Session 5: Abstract presentations

Chairs:                      to be announced


10.00-10.50   Keynote lecture: Kidney organoids

to be announced


10.50-11.20 Coffee/tea


11.20-12.50 Joint session with VCA and BSC as part of ESOT2019

VCA quo vadis?

Chairs:                      to be announced

11:20 – 11:50            Advances in organ preservation and machine perfusion: potential impact on VCA

Annemarie Weissenbacher, Oxford University, UK / Innsbruck Medical University, Austria

11:50 – 12:20            Thinking outside the box: Combining VCA and regenerative medicine?

Robert Rieben, Bern, Switzerland


12:20 – 12:50            Cell-based immunoregulation and tolerance induction: are we getting any closer?

Fadi Issa, Oxford University, United Kingdom


12.50 Closing